Training Grant in Cancer Biology

描述（由申请人提供）：本申请旨在为综合癌症生物学（ICB）的一项新计划提供资金，以培养致力于癌症研究事业的博士后和博士前学员。该计划将设在马里兰州Greenebaum（UMG）癌症中心的大学，并包括来自马里兰州巴尔的摩校园的多个基础科学和临床部门的教师。参与的学院是根据他们的科学成就和癌症研究的资助记录，对转化癌症研究的兴趣和指导学员的经验而选择的。这个多学科计划的一个主要目标是为学员提供一个令人兴奋和刺激的学术环境，在其中进行跨学科的癌症研究，利用尖端技术，使深刻的发现，将导致下一代敏感的诊断和特定的治疗。学员将获得对转化癌症研究的赞赏，并能够与指导他们职业生涯的科学家和临床医生的互动团队进行有效互动。两个关键的发展证实了马里兰州大学对癌症研究的承诺，并证明了我们对培训计划的要求。首先是成立UMG癌症中心，其使命是整合创新的基础，转化和临床研究，以影响癌症的理解，诊断，治疗和预防，并为癌症患者提供最先进的临床护理。UMG癌症中心于2008年获得美国国家癌症研究所（NCI）指定的癌症中心的资助，以表彰其卓越的科学成就和出色的患者护理。第二，在生命科学研究生课程的分子医学课程内形成了一个新的跨部门的癌症生物学研究生课程。ICB培训计划建立在癌症生物学研究生课程的基础上，并与UMG癌症中心的课程相结合。它是高度“跨学科”的范围，使学生能够在基础，转化和临床癌症研究的许多不同方面获得坚实的基础，但允许他们灵活地专注于自己感兴趣的领域。ICB培训计划的一个真实的优势是拥有几乎所有当代生物医学科学专业知识的庞大而多样化的癌症教师群体指导学员的能力。我们的博士前和博士后学员有机会在互动，多学科的环境中使用最先进的方法来研究癌症的分子基础，并与临床研究-ICB培训计划的独特资产相结合。

DESCRIPTION (provided by applicant): This application seeks funding of a new program in Integrative Cancer Biology (ICB) to train post-doctoral and pre-doctoral trainees committed to careers in cancer research. The program will be based in the University of Maryland Greenebaum (UMG) Cancer Center, and includes faculty from multiple basic science and clinical departments on the University of Maryland Baltimore campus. Participating Faculty have been selected based on their scientific achievements and track record of funding in cancer research, interest in translational cancer research and experience in mentoring trainees. A major goal of this multi-disciplinary program is to provide trainees with an exciting and stimulating academic environment in which to pursue interdisciplinary cancer research, utilizing cutting edge technologies to make profound discoveries that will lead to the next generation of sensitive diagnostics and specific therapeutics. Trainees are provided with an appreciation for translational cancer research and with the ability to interact effectively with interactive teams of scientists and clinicians that will guide their careers. Two key developments substantiate the commitment of the University of Maryland to cancer research and justify our request for a training program. The first was the establishment of the UMG Cancer Center, whose mission is to integrate innovative basic, translational and clinical research to impact the understanding, diagnosis, treatment and prevention of cancer, and to provide state-of-the-art clinical care for cancer patients. The UMG Cancer Center was funded as a National Cancer Institute (NCI)-designated cancer center in 2008 in recognition of its scientific excellence and outstanding patient care. Second, a new inter-departmental graduate program in Cancer Biology was formed within the Molecular Medicine Program of the Graduate Program of Life Sciences. The ICB training program builds on the Cancer Biology graduate program and is integrated with the programs of the UMG Cancer Center. It is highly "interdisciplinary" in scope and enables students to obtain a solid grounding in many different aspects of basic, translational and clinical cancer research, yet allows them the flexibility to specialize in their area of interest. A real strength of the ICB training program is the capacity of the large, diverse group of cancer faculty with expertise in virtually all contemporary biomedical science to mentor trainees. Our pre-doctoral and post-doctoral trainees have the opportunity to investigate the molecular basis of cancer using state-of-the-art methodologies in an interactive, multidisciplinary environment, and in conjunction with clinical research--distinctive assets of the ICB Training program.